Literature DB >> 32152466

Selective targeting of α4β1 integrin attenuates murine graft versus host disease.

Bader Alahmari1, Matthew L Cooper1, Kiran Vij1, Julie Ritchey1, Peter Ruminski1, Feng Gao2, Jaebok Choi3, John F DiPersio4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32152466      PMCID： PMC7483240          DOI： 10.1038/s41375-020-0786-0

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects.

Authors:  Kristina Maas-Bauer; Juliane K Lohmeyer; Toshihito Hirai; Teresa Lopes Ramos; Furqan M Fazal; Ulrike M Litzenburger; Kathryn E Yost; Jessica V Ribado; Neeraja Kambham; Arielle S Wenokur; Po-Yu Lin; Maite Alvarez; Melissa Mavers; Jeanette Baker; Ami S Bhatt; Howard Y Chang; Federico Simonetta; Robert S Negrin
Journal:  Blood       Date:  2021-09-09       Impact factor: 25.476

2.  Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR.

Authors:  Sena Kim; Kidist Ashami; Sora Lim; Karl Staser; Kiran Vij; Srikanth Santhanam; Julie Ritchey; Sarah Peterson; Feng Gao; Matthew A Ciorba; Matthew L Cooper; John F DiPersio; Jaebok Choi
Journal:  Leukemia       Date:  2021-07-24       Impact factor: 12.883

3.  DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo.

Authors:  Masaki Ohyagi; Tetsuya Nagata; Kensuke Ihara; Kie Yoshida-Tanaka; Rieko Nishi; Haruka Miyata; Aya Abe; Yo Mabuchi; Chihiro Akazawa; Takanori Yokota
Journal:  Nat Commun       Date:  2021-12-22       Impact factor: 14.919

4.  Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients.

Authors:  Susan Trümpelmann; Andreas Schulte-Mecklenbeck; Olga V Steinberg; Timo Wirth; Manfred Fobker; Lisa Lohmann; Jan D Lünemann; Heinz Wiendl; Catharina C Gross; Luisa Klotz
Journal:  Clin Transl Sci       Date:  2022-03-04       Impact factor: 4.438
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.